In vitro and in vivo biocompatibility of ReOss® in powder and putty configurations

Andréa Vaz Braga Pintor, Rodrigo Figueiredo de Brito Resende, Adriana Terezinha Novelino Neves, Gutemberg Gomes Alves, Paulo G. Coelho, José Mauro Granjeiro, Monica Diuana Calasans-Maia

Research output: Contribution to journalArticlepeer-review


This study evaluated comparatively two configurations (powder and putty) of a composite biomaterial based on PLGA (Poly(lactide-co-glycolide)/nanoescale hydroxyapatite (ReOss®, Intra-Lock International) through microscopic morphology, in vitro cytotoxicity, biocompatibility and in vivo response as a bone substitute. SEM and EDS characterized the biomaterials before/after grafting. Cytocompatibility was assessed with murine pre-osteoblasts. Osteoconductivity and biocompatibility were evaluated in White New Zealand rabbits. Both configurations were implanted in the calvaria of eighteen animals in non-critical size defects, with blood clot as the control group. After 30, 60 and 90 days, the animals were euthanized and the fragments containing the biomaterials and controls were harvested. Bone blocks were embedded in paraffin (n=15) aiming at histological and histomorphometric analysis, and in resin (n=3) aiming at SEM and EDS. Before implantation, the putty configuration showed both a porous and a fibrous morphological phase. Powder revealed porous particles with variable granulometry. EDS showed calcium, carbon, and oxygen in putty configuration, while powder also showed phosphorus. After implantation EDS revealed calcium, carbon, and oxygen in both configurations. The materials were considered cytotoxic by the XTT test. Histological analysis showed new bone formation and no inflammatory reaction at implant sites. However, the histomorphometric analysis indicated that the amount of newly formed bone was not statistically different between experimental groups. Although both materials presented in vitro cytotoxicity, they were biocompatible and osteoconductive. The configuration of ReOss® affected morphological characteristics and the in vitro cytocompatibility but did not impact on the in vivo biological response, as measured by the present model.

Original languageEnglish (US)
Pages (from-to)117-127
Number of pages11
JournalBrazilian Dental Journal
Issue number2
StatePublished - Mar 1 2018


  • Biocompatibility testing
  • Hydroxyapatite
  • Materials testing
  • Nanotechnology
  • PLGA

ASJC Scopus subject areas

  • General Dentistry


Dive into the research topics of 'In vitro and in vivo biocompatibility of ReOss® in powder and putty configurations'. Together they form a unique fingerprint.

Cite this